ProjectPeriodLocation(s)NPrimary outcomeStudy namePrincipal InvestigatorInstitute
CORESMA--2 locations in Germany, Nepal9000Seroprevalence of SARS-Cov-2 antibodies in Nepal and GermanyCovid-19 Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation ResearchGérard KrauseHelmholtz HZI
MuSPAD2020-06 -- 2021-055 locations in Germany60000Seroprevalence, stratified by age and over timeMultilocal and serial prevalence study for antibodies against SARS-2 coronavirus in GermanyGérard KrauseHelmholtz HZI
SCENARIO2020-06 -- 2021-011 location in Germany2400Rate of seropositive pregnancies in each of the three consecutive time cohortsPrevalence of SARS-CoV-2 in pregnancy in Franconia (SCENARIO)PD Dr. med. Alexander HeinDepartment of Gynaecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
ProCoV2020-04-14 -- 2021-06-161 location in Germany871How many employees develop a COVID-19 positive test and how many develop antibodies in the sense of a seroconversion?Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in GermanyTim StrateHospital Reinbek
PrEP-Co2020-05-18 -- ongoing1 location in Germany300Seroconversion rate of SARS-CoV-2 antibody during one year of follow-up.SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic: THE PREP-CO STUDYChristoph SpinnerRechts der Isar Hospital, Department for Internal Medicine II
SARS-CoV-2 seroprevalence study2020-07 -- 2020-101 location in Germany1500Seroprevalence for SARS-CoV-2, stratified by age over timeSerial cross-sectional seroprevalence study of SARS-CoV-2 infection during and post-epidemic periods in Heidelberg and the Rhein-Neckar region, GermanyClaudia DenkingerUniversity Hospital Heidelberg, Division of Tropical Medicine
SESCiB2020-09 -- 2021-041 location in Colombia1000(1) Seroprevalence of SARS-Cov-2, (2) Asymptomatic infection ratio, (3) Associated clinical, socioeconomic, and demographic factors.Seroepidemiologic study on SARS CoV2 infection in scholar children in Bogotá, ColombiaGérard Krause and Fernando Pio De La Hoz RestrepoHelmholtz (HZI) and Universidad Nacional de Colombia
CoNAN2020-05 -- 2020-051 location in Germany626Seroprevalence for SARS-CoV-2Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR sampled and quarantined community after a COVID-19 outbreak - the CoNAN studyMathias W. Pletz and Sebastian WeisInstitute for Infectious Diseases and Infection Control, Jena University Hospital (07747 Jena, Germany)
SLKovid2020-07-01 -- 2020-12-311 location in Germany3000Serum analyses of antibodies against SARS-CoV-2 at 0 (if positive, additionalley at 3, 6 and 12 months) plus questionnaireSLKovid Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19)Uwe MartensSLK Kliniken
STAAB2020-06 --Deutschland4864Seroprävalenz in der Allgemeinbevölkerung in Abhängigkeit von soziodemographischen Faktoren, kardiovaskulären Risikofaktoren und psychosozialen DeterminantenSTAAB Kohortenstudie – Häufigkeit und Einflussfaktoren auf frühe STAdien A und B der Herzinsuffizienz in der Bevölkerung – COVID-19 UnterstudieProf. Peter U Heuschmann, Prof. Stefan StörkInstitut für Klinische Epidemiologie und Biometrie Würzburg / Deutsches Zentrum für Herzinsuffizienz
Wü-KiTa-CoV2020-10 --1 location in Germany1000Assessment of acceptance rates of various surveillance measures for the detection of SARS-CoV-2 infections in daycare children, staff, and their household members; detection of SARS-CoV-2 infections via PCR from nasal swaps or saliva samples from daycare children and staff; for household members from throat swaps;Würzburg Childcare Study during the COVID-19 pandemic - A study into the acceptance of different screening measures for the detection of infections with the novel coronavirus (SARS-CoV-2) in child daycare centres in WürzburgOliver Kurzai and Johannes LieseUniversity Würzburg